Drug Shortage Report for GD-DICLOFENAC/MISOPROSTOL 75

Last updated on 2020-11-12 History
Report ID 125376
Drug Identification Number 02341697
Brand name GD-DICLOFENAC/MISOPROSTOL 75
Common or Proper name GD-DICLOFENAC/MISOPROSTOL
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) DICLOFENAC SODIUM MISOPROSTOL
Strength(s) 75MG 200MCG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 250's
ATC code M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-09-30
Estimated end date 2020-11-16
Actual end date 2020-11-11
Shortage status Resolved
Updated date 2020-11-12
Company comments Limited inventory available and on preventative allocation.
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-11-12 French Compare
v5 2020-11-12 English Compare
v4 2020-10-01 English Compare
v3 2020-09-30 French Compare
v2 2020-09-30 French Compare
v1 2020-09-30 English Compare

Showing 1 to 6 of 6